Press Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Apr 25, 2017Boston Scientific today announced results from the RANGER SFA trial for the Ranger™ Paclitaxel-Coated PTA Balloon Catheter at the Charing Cross Symposium, in London. Data demonstrated that the drug-coated balloon (DCB) exhibited both a high rate of primary patency and freedom from target lesion revascularization (TLR) at 12 months, reducing the need for re-interventions to re-establish flow in previously blocked blood vessels.
The prospective, randomized, controlled trial, comparing the Ranger DCB to uncoated PTA balloons, included 105 patients with femoropopliteal lesions, at ten centers in Europe. Results demonstrate...
-
Mar 16, 2017Extended battery life of Boston Scientific devices attributed to reduction in replacement procedures and complications; has potential for significant cost savings
Today, the National Institute for Health and Care Excellence (NICE) issued medical technology guidance recommending the use of Boston Scientific Corporation (NYSE: BSX) cardiac resynchronization...
-
Mar 16, 2017Si ritiene che la durata prolungata della batteria dei dispositivi di Boston Scientific contribuisca alla riduzione degli interventi di sostituzione e delle complicanze e che possa potenzialmente determinare risparmi economici significativi
Oggi, il National Institute for Health and Care Excellence (NICE) ha emanato delle indicazioni mediche e tecnologiche nelle quali si consiglia l’uso dei defibrillatori per la terapia di...
-
Mar 16, 2017Die verlängerte Funktionsdauer der Geräte trägt zu einer Reduktion von Wechseleingriffen und damit verbundenen Komplikationen bei und kann so zu signifikanten Kosteneinsparungen führen
MARLBOROUGH, Mass., USA (16. März 2017) Das britische National Institute for Health and Care Excellence (NICE) hat heute Leitlinien zur Anwendung medizinischer Technologie herausgegeben, die für...
-
Mar 16, 2017El NICE recomienda los dispositivos TRC-D de Boston Scientific con batería ENDURALIFE™ para el tratamiento de la insuficiencia cardíaca
El Instituto Nacional británico para la Salud y la Excelencia en la Atención médica (NICE) ha emitido una recomendación sobre tecnología médica a favor del uso de los desfibriladores con...